TrialCritical care (London, England)2023

Polymorphism in interferon alpha/beta receptor contributes to glucocorticoid response and outcome of ARDS and COVID-19.

Juho Jalkanen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.